INNOCAN PHARMA CORPORATION financial statements, including revenue, expenses, profit, and loss
The total revenue of INNO for the last quarter is 9.13 M CAD, and it's 36.96% higher compared to the previous quarter. The net income of Q1 24 is -2.38 M CAD.